Investigations of Possible Low-Level Temperature and Moisture Anomalies During the AMIE Field Campaign on Manus Island

This document discusses results stemming from the investigation of near-surface temperature and moisture “oddities” that were brought to light as part of the Atmospheric Radiation Measurement (ARM) Madden-Julian Oscillation (MJO) Investigation Experiment (AMIE), Dynamics of the Madden-Julian Oscillation (DYNAMO), and Cooperative Indian Ocean experiment on intraseasonal variability in the Year 2011 (CINDY2011) campaigns

Luminescence dating of soils and sediments from Jerash, Jordan

The urban site of Jerash, Jordan is recognised as one of the great cities of the classical Middle East and has been the subject of ongoing systematic archaeological investigations since the 1920s. Its significance lies in its location on limestone geology in one of the more fertile areas of the Ajlun Highlands in northern Jordan with a good water supply, a number of springs and its central position in regional trade routes. The hinterland context of the city is yet to be considered and is a significant omission given the importance of water and its management together with the agricultural systems dependent on water in supporting urban development. Landscape chronologies are vital to the establishment of city and hinterland relationships and in this working papers we assess the value and significance of optically stimulated luminescence (OSL) measurement in this endeavour. Our findings so far suggest a measurement cluster range of ca. 480 BC – 250 BC in landscapes underlying the city and a dominant trend of sediments infilling the adjacent Wadi Suf between 640 ± 240 AD and 1400 ± 60 AD reflecting land management changes in a soil environment sensitive to degradation

Urban gardens in Antiquity : the case of Gerasa/Jerash in Jordan

Funding: the Carlsberg Foundation, the Danish National Research Foundation (grant 119), the Deutsche Forschungsgemeinschaft, the Deutscher Palästina-Verein, the Danish EliteForsk Award and H. P. Hjerl Hansens mindefondet for Dansk Palæstinaforskning. Financial support for the OSL analyses was provided by the Scottish Alliance for Geoscience, Environment and Society (SAGES).In the Eastern Mediterranean, where some of the earliest known urban cities are located, relatively little is known about urban soils in archaeological contexts. Red Mediterranean Soil (RMS) is a hallmark of the Mediterranean region while the impact of long-term urbanization on RMS material is understudied. In this article we present evidence of RMS from the longue durée cityscape of Jerash, Jordan, to determine how humans have used, modified and impacted RMS material in an urban context. Thin-sections were made of twelve RMS samples, and micromorphological studies on several in-situ but disturbed soils adjacent to bedrock were conducted, spanning the initial surface soil disturbances in the Hellenistic and Roman period occupation, as well as transported RMS material spanning the Roman through Umayyad periods (until the earthquake of 749 CE). We compared the on-site inner-urban red soils to natural RMS in the area and found that some characteristics reflect their origin in the Pleistocene soils, while other traits reflect human impact related to urban activities. The majority of the on-site samples contained evidence comparable to modern centers, including changes of structure, texture, inclusions, as well as high levels of contamination of heavy metals and phosphorus (P), which combined are strong signs of urban activity. Evidence including textural pedofeatures, fragmented peds, mixed fabrics, sorting of silt-sized material likely reflect the use of RMS in urban gardens and cultivation. Black carbon inclusions within the fabric contain evidence for burning of organic matter in connection with various anthropogenic activities, likely re-dispersed via aeolian and water erosion processes. Heavy metal enrichments, which are associated with production and artisanal activities, may also have been disseminated by both aeolian and surface water processes, possibly in conjunction with irrigation undertaken with polluted water. Contrasting soil fabrics and inclusion features observed in thin section together with elemental analayses characterizes the nature of urban cultivation in its environmental context at Jerash, where city life was maintained for over 800 years. With cultivated soils in urban areas increasingly evidenced in archaeological stratigraphies from different regions of the world, our approach offers new insight into the vital contributions that these soils and their management has made to the food security, resilience and longevity of early city life.Publisher PDFPeer reviewe

A Roman provincial city and its contamination legacy from artisanal and daily-life activities

Funding: This project was supported by the Carlsberg Foundation (R.R., www.carlsbergfondet.dk, Grant CF14-0467), Danish National Research Foundation (R.R., www.dg.dk, Grant 119), the Deutsche Forchungsgemeinschaft (A.L., https://www.dfg.de/, grant nos LI978/4-1 and LI978/4-2), the Deutscher Palästinaverein (A.L., https://www.palaestina-verein.de/), the Danish EliteForsk Award (R.R., https://ufm.dk/forskning-og-innovation/forskningsformidling/eliteforsk, grant 4094-00077B), and H. P. Hjerl Hansens Mindefondet for Dansk Palæstinaforskning (RR).Roman metal use and related extraction activities resulted in heavy metal pollution and contamination, in particular of Pb near ancient mines and harbors, as well as producing a global atmospheric impact. New evidence from ancient Gerasa (Jerash), Jordan, suggests that small-scale but intense Roman, Byzantine and Umayyad period urban, artisanal, and everyday site activities contributed to substantial heavy metal contamination of the city and its hinterland wadi, even though no metal mining took place and hardly any lead water pipes were used. Distribution of heavy metal contaminants, especially Pb, observed in the urban soils and sediments within this ancient city and its hinterland wadi resulted from aeolian, fluvial, cultural and post-depositional processes. These represent the contamination pathways of an ancient city-hinterland setting and reflect long-term anthropogenic legacies at local and regional scales beginning in the Roman period. Thus, urban use and re-use of heavy metal sources should be factored into understanding historical global-scale contaminant distributions.Publisher PDFPeer reviewe

Predicting biodiversity loss in island and countryside ecosystems through the lens of taxonomic and functional biogeography

We investigate how variation in patch area and forest cover quantified for three different spatial scales (buffer size of 500, 1500 and 3000 m radius) affects species richness and functional diversity of bat assemblages in two ecosystems differing in fragment–matrix contrast: a landbridge island system in Panama and a countryside ecosystem in the Brazilian Amazon. Bats were sampled on 11 islands and the adjacent mainland in Panama, and in eight forest fragments and nearby continuous forest in Brazil. Species–area relationships (SAR) were assessed based on Chao1 species richness estimates, and functional diversity–area relationships (FAR) were quantified using Chao1 functional diversity estimates measured as the total branch length of a trait dendrogram. FARs were calculated using three trait sets: considering five species functional traits (FARALL), and trait subsets reflecting ‘diet breadth’ (FARDIET) and ‘dispersal ability’ (FARDISPERSAL). We found that in both study systems, FARALL was less sensitive to habitat loss than SAR, in the sense that an equal reduction in habitat loss led to a disproportionately smaller loss of functional diversity compared to species richness. However, the inhospitable and static aquatic matrix in the island ecosystem resulted in more pronounced species loss with increasing loss of habitat compared to the countryside ecosystem. Moreover, while we found a significant FARDISPERSAL for the island ecosystem in relation to forest cover within 500 m landscape buffers, FARDIET and FARDISPERSAL were not significant for the countryside ecosystem. Our findings highlight that species richness and functional diversity in island and countryside ecosystems scale fundamentally differently with habitat loss, and suggest that key bat ecological functions, such as pollination, seed dispersal and arthropod suppression, may be maintained in fragments despite a reduction in species richness. Our study reinforces the importance of increasing habitat availability for decreasing the chances of losing species richness in smaller fragments

Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's disease

Introduction: While the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) was ongoing, external data suggested higher doses were needed to achieve targeted effects; therefore, doses of gantenerumab were increased 5-fold, and solanezumab was increased 4-fold. We evaluated to what extent mid-trial dose increases produced a dose-dependent treatment effect. Methods: Using generalized linear mixed effects (LME) models, we estimated the annual low- and high-dose treatment effects in clinical, cognitive, and biomarker outcomes. Results: Both gantenerumab and solanezumab demonstrated dose-dependent treatment effects (significant for gantenerumab, non-significant for solanezumab) in their respective target amyloid biomarkers (Pittsburgh compound B positron emission tomography standardized uptake value ratio and cerebrospinal fluid amyloid beta 42), with gantenerumab demonstrating additional treatment effects in some downstream biomarkers. No dose-dependent treatment effects were observed in clinical or cognitive outcomes. Conclusions: Mid-trial dose escalation can be implemented as a remedy for an insufficient initial dose and can be more cost effective and less burdensome to participants than starting a new trial with higher doses, especially in rare diseases. Highlights: We evaluated the dose-dependent treatment effect of two different amyloid-specific immunotherapies. Dose-dependent treatment effects were observed in some biomarkers. No dose-dependent treatment effects were observed in clinical/cognitive outcomes, potentially due to the fact that the modified study may not have been powered to detect such treatment effects in symptomatic subjects at a mild stage of disease exposed to high (or maximal) doses of medication for prolonged durations

Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer

To examine whether there are any characteristics of women or their initial tumors that might be useful for tailoring surveillance recommendations to optimize outcomes. We followed 17,286 women for up to 5 years after an initial diagnosis of ductal carcinoma in situ (DCIS) or early stage (I/II) invasive breast cancer diagnosed between 1996 and 2006. We calculated rates per 1,000 women years of recurrences and second breast primaries relative to demographics, risk factors, and characteristics of initial diagnosis: stage, treatment, mode of initial diagnosis. Nearly 4% had a second breast cancer event (314 recurrences and 344 second breast primaries). Women who used adjuvant hormonal therapy or were ≥80 years had the lowest rates of second events. Factors associated with higher recurrence and second primary rates included: initial DCIS or stage IIB, estrogen/progesterone receptor-negative, younger women (<50 years). Women with a family history or greater breast density had higher second primary rates, and women who received breast conserving surgery without radiation had higher recurrence rates. Roughly one-third of recurrences (37.6%) and second primaries (36.3%) were not screen-detected. Initial mode of diagnosis was a predictor of second events after adjusting for age, stage, primary treatment, and breast density. A recent negative mammogram should not falsely reassure physicians or women with new breast symptoms or changes because one-third of second cancers were interval cancers. This study does not provide any evidence in support of changing surveillance intervals for different subgroups

Barking up the same tree: a comparison of ethnomedicine and canine ethnoveterinary medicine among the Aguaruna

<p>Abstract</p> <p>Background</p> <p>This work focuses on plant-based preparations that the Aguaruna Jivaro of Peru give to hunting dogs. Many plants are considered to improve dogs' sense of smell or stimulate them to hunt better, while others treat common illnesses that prevent dogs from hunting. This work places canine ethnoveterinary medicine within the larger context of Aguaruna ethnomedicine, by testing the following hypotheses: H1 -- Plants that the Aguaruna use to treat dogs will be the same plants that they use to treat people and H2 -- Plants that are used to treat both people and dogs will be used for the same illnesses in both cases.</p> <p>Methods</p> <p>Structured interviews with nine key informants were carried out in 2007, in Aguaruna communities in the Peruvian department of Amazonas. Informants provided freelists of plants given to dogs and explained the purpose, preparation and route of administration used. For each plant, informants also described any uses for treating people. Botanical voucher specimens were collected and additional informal observations were made, accompanying people on hunting trips.</p> <p>Results</p> <p>Out of 35 plant species given to dogs, 29 (83%) are also given to humans for some medicinal purpose, while five are used only for dogs. However, the same plant is used to treat the same illness in both humans and dogs in only 53% of the cases. Forty-three percent of plants used to treat a particular illness for both dogs and people are administered in the same manner for both.</p> <p>Conclusion</p> <p>Results suggest that Aguaruna canine ethnoveterinary medicine is, at least partly, an independent cognitive domain. Some of the difference in plant use between dogs and people can be explained by the fact that certain diseases mentioned only apply to dogs. Although reports of canine ethnoveterinary medicine are very sparse in the literature, Aguaruna practices show some similarities with a few trends reported for other Amazonian societies, particularly, in the prevalence of the nasal route of administration, the use of plant-based psychoactives and in the importance of ants and wasps, in some form, for training dogs.</p

Avoid or Embrace? Practice Effects in Alzheimer's Disease Prevention Trials

Demonstrating a slowing in the rate of cognitive decline is a common outcome measure in clinical trials in Alzheimer’s disease (AD). Selection of cognitive endpoints typically includes modeling candidate outcome measures in the many, richly phenotyped observational cohort studies available. An important part of choosing cognitive endpoints is a consideration of improvements in performance due to repeated cognitive testing (termed “practice effects”). As primary and secondary AD prevention trials are comprised predominantly of cognitively unimpaired participants, practice effects may be substantial and may have considerable impact on detecting cognitive change. The extent to which practice effects in AD prevention trials are similar to those from observational studies and how these potential differences impact trials is unknown. In the current study, we analyzed data from the recently completed DIAN-TU-001 clinical trial (TU) and the associated DIAN-Observational (OBS) study. Results indicated that asymptomatic mutation carriers in the TU exhibited persistent practice effects on several key outcomes spanning the entire trial duration. Critically, these practice related improvements were larger on certain tests in the TU relative to matched participants from the OBS study. Our results suggest that the magnitude of practice effects may not be captured by modeling potential endpoints in observational studies where assessments are typically less frequent and drug expectancy effects are absent. Using alternate instrument forms (represented in our study by computerized tasks) may partly mitigate practice effects in clinical trials but incorporating practice effects as outcomes may also be viable. Thus, investigators must carefully consider practice effects (either by minimizing them or modeling them directly) when designing cognitive endpoint AD prevention trials by utilizing trial data with similar assessment frequencies

Amyloid-related imaging abnormalities in the DIAN-TU-001 trial of gantenerumab and solanezumab: lessons from a trial in dominantly inherited Alzheimer disease

OBJECTIVE: To determine the characteristics of participants with amyloid-related imaging abnormalities (ARIA) in a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease (DIAD). METHODS: 142 DIAD mutation carriers received either gantenerumab SC (n=52), solanezumab IV (n=50), or placebo (n=40). Participants underwent assessments with the Clinical Dementia Rating® (CDR®), neuropsychological testing, CSF biomarkers, β-amyloid positron emission tomography (PET), and magnetic resonance imaging (MRI) to monitor ARIA. Cross-sectional and longitudinal analyses evaluated potential ARIA-related risk factors. RESULTS: Eleven participants developed ARIA-E, including 3 with mild symptoms. No ARIA-E was reported under solanezumab while gantenerumab was associated with ARIA-E compared to placebo (OR=9.1, CI[1.2, 412.3]; p=0.021). Under gantenerumab, APOE-ɛ4 carriers were more likely to develop ARIA-E (OR=5.0, CI[1.0, 30.4]; p=0.055), as were individuals with microhemorrhage at baseline (OR=13.7, CI[1.2, 163.2]; p=0.039). No ARIA-E was observed at the initial 225mg/month gantenerumab dose, and most cases were observed at doses >675mg. At first ARIA-E occurrence, all ARIA-E participants were amyloid-PET+, 60% were CDR>0, 60% were past their estimated year to symptom onset, and 60% had also incident ARIA-H. Most ARIA-E radiologically resolved after dose adjustment and developing ARIA-E did not significantly increase odds of trial discontinuation. ARIA-E was more frequently observed in the occipital lobe (90%). ARIA-E severity was associated with age at time of ARIA-E. INTERPRETATION: In DIAD, solanezumab was not associated with ARIA. Gantenerumab dose over 225mg increased ARIA-E risk, with additional risk for individuals APOE-ɛ4(+) or with microhemorrhage. ARIA-E was reversible on MRI in most cases, generally asymptomatic, without additional risk for trial discontinuation. This article is protected by copyright. All rights reserved